Armata Pharmaceuticals: Funding, Investors & Team (Sep 2026)
Armata Pharmaceuticals is a biotechnology company that is in the process of developing bacteriophage therapeutics that are targeted specifically for drug-resistant bacterial infections. Due to the excessive use of antibiotics, there has been a significant increase in multidrug-resistant bacteria, which has brought us closer to a time where common infections can be severe or even life-threatening. Furthermore, the use of broad-spectrum antibiotics has been known to disrupt the balance of the human microbiome, leading to disease. Established in 2005, the company is located in Marina del Rey, CA, USA.
Armata Pharmaceuticals has raised $105M across 8 funding rounds on record, the most recent an undisclosed round of $2.5M announced in Jun 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Armata Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Armata Pharmaceuticals Funding Rounds
Armata Pharmaceuticals raised $7.0M in a Post-IPO Equity announced in Oct 2021.
1.8 years later, an undisclosed round of $25.0M was announced in Jul 2023.
8 months later, an undisclosed round of $35.0M was announced in Mar 2024.
4 months later, an undisclosed round of $5.3M was announced in Jul 2024.
8 months later, an undisclosed round of $10.0M was announced in Mar 2025.
2 months later, an undisclosed round of $4.7M was announced in May 2025.
3 months later, an undisclosed round of $15.0M was announced in Aug 2025.
10 months later, an undisclosed round of $2.5M was announced in Jun 2026.
Armata Pharmaceuticals Founders and Leadership Team
Contact details for the Armata Pharmaceuticals team: 1 of 3 have an email address on file.
Start 14-day free trial →Armata Pharmaceuticals Funding Compared to Other Biotechnology Startups
Armata Pharmaceuticals' latest round of $2.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Armata Pharmaceuticals in Biotechnology and Marina Del Rey
Companies Similar to Armata Pharmaceuticals
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Armata Pharmaceuticals Funding FAQs
What does Armata Pharmaceuticals do?
Armata Pharmaceuticals is a biotechnology company that is in the process of developing bacteriophage therapeutics that are targeted specifically for drug-resistant bacterial infections. Due to the excessive use of antibiotics, there has been a significant increase in multidrug-resistant bacteria, which has brought us closer to a time where common infections can be severe or even life-threatening. Furthermore, the use of broad-spectrum antibiotics has been known to disrupt the balance of the human microbiome, leading to disease. Established in 2005, the company is located in Marina del Rey, CA, USA.
How much funding has Armata Pharmaceuticals raised?
Armata Pharmaceuticals has raised $105M across 8 rounds on record. The most recent is an undisclosed round of $2.5M announced in Jun 2026.
When did Armata Pharmaceuticals last raise funding?
Armata Pharmaceuticals' most recent funding round on record is an undisclosed round of $2.5M, announced in Jun 2026.
Who founded Armata Pharmaceuticals?
FundedIQ lists Todd Patrick (Founder), Wenyuan Shi (Founder) at Armata Pharmaceuticals.
Who is the CEO of Armata Pharmaceuticals?
Brian Varnum is listed as CEO at Armata Pharmaceuticals.
Where is Armata Pharmaceuticals headquartered?
Armata Pharmaceuticals is based in Marina Del Rey, California, United States.
How many employees does Armata Pharmaceuticals have?
Armata Pharmaceuticals is in the 51-100 employee band.
How does Armata Pharmaceuticals' funding compare to other Biotechnology startups?
Armata Pharmaceuticals' latest round of $2.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Armata Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Armata Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.